Pre-clinical Technical Focus
AGADA leadership (Dr. Nagaraju) helped develop international standard operating procedures (SOPs) for efficacy testing in neuromuscular disease models.
AGADA was founded to meet the growing needs for pre-clinical efficacy studies both as a key step in Sponsors de-risking their programs, and also for supporting orphan drug designation (FDA, EMA).
AGADA leadership will work with your team for robust experimental design, then our scientists carry out your study in a rigorous QA/QC environment.
We are effective communicators with your staff, and provide timely feedback and reporting.
AGADA was founded to meet the growing needs for pre-clinical efficacy studies both as a key step in Sponsors de-risking their programs, and also for supporting orphan drug designation (FDA, EMA).
AGADA leadership will work with your team for robust experimental design, then our scientists carry out your study in a rigorous QA/QC environment.
We are effective communicators with your staff, and provide timely feedback and reporting.
